TOI ONCOLOGY INSTITUTE INC (THE)

The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit

The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit

CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based Care” panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024.

About The Oncology Institute, Inc.

Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit .

Investors

Solebury Strategic Communications



EN
07/05/2024

Underlying

TOIONCOLOGY INSTITUTE INC (THE)

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ONCOLOGY INSTITUTE INC (THE)

 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute Reports First Quarter 2024 Financial Results an...

The Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Guidance CERRITOS, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended March 31, 2024. Recent Operational Highlights Include: Successfully completed integration of first capitated risk contract direct to a health plan, and launched MSO model to enhance employed clinic locations, in the Florida mark...

May 14, 2024 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute to Participate in Panel Discussion at the Leeri...

The Oncology Institute to Participate in Panel Discussion at the Leerink Healthcare Transformation Summit CERRITOS, Calif., May 07, 2024 (GLOBE NEWSWIRE) --  (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate in the “Defining the Next Chapter in Value-Based Care” panel at the Leerink Healthcare Transformation Summit in Montecito at 8:30am ET on May 16, 2024. About The Oncology Institute, Inc. Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI)...

May 7, 2024 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute Announces First Quarter 2024 Earnings Release D...

The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call CERRITOS, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2024 financial results after the market close on Tuesday, May 14, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-...

April 23, 2024 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

Jordan McInerney Appointed as Chief Development Officer of The Oncolog...

Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute Executive Brings Wealth of Experience in Advancing Value-Based Specialty Care Models CERRITOS, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is pleased to announce the appointment of Jordan McInerney as the new Chief Development Officer (CDO), effective April 1, 2024. In this role, Mr. McInerney will spearhead growth initiatives for The Oncology Institute across diverse markets, including cultivating new partnerships with payors, driving M&A pr...

April 8, 2024 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute and Healthly Forge Strategic Alliance to Elevat...

The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California CERRITOS, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) and Healthly, a rapidly growing healthcare company with over 180 primary care physicians, support services, and a focus on preventive medicine, have announced a strategic collaboration aimed at extending high-quality cancer care services to patients throughout Southern California. Commencing July 1, 2024, TOI will offer its cancer care ser...

April 4, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch